Latest Form 4 insider transactions

NASDAQ
Ishay Davidi, a Director and 10% owner of Kamada Ltd, reported multiple transactions in common stock on August 27, 2026.
NASDAQ
Sagit Manor, CFO of Nayax Ltd., sold 293 shares of common stock on September 28, 2026 for $44.80 per share.
NASDAQ
Oren Tepper, CRO of Nayax Ltd., sold 131 shares of common stock on September 28, 2026 for $44.63 per share.
NASDAQ
Uri Botzer, a Director of Kamada Ltd, reported multiple transactions in common stock on August 27, 2026.
NASDAQ
Michal Sever, CMO of Nayax Ltd., sold 35 shares of common stock on September 28, 2026 for $44.63 per share.
NASDAQ
Eden Zafrani, CHRO of Nayax Ltd., sold 200 shares of common stock on September 28, 2026 for $44.63 per share.
NASDAQ
Carly Lisanne Furman, CEO NAYX North America of Nayax Ltd., sold 219 shares of common stock on September 28, 2026 for $45.01 per share.
NASDAQ
Aaron Samuel Greenberg, CSO of Nayax Ltd., sold 54 shares of common stock on September 28, 2026 for $44.63 per share.
AMEX
Siew Wai Yong, CHAIRMAN AND CEO, a Director and 10% owner of Trio-Tech International, reported multiple transactions in common stock on September 28, 2026.
NASDAQ
Hui Jin, Chief Executive Officer of H World Group Ltd, reported multiple transactions in common stock on September 26, 2026.
NASDAQ
Andrew Y Yan, a Director of Qifu Technology, Inc., sold 850 shares of common stock on September 29, 2026 for $3.54 per share.
NASDAQ
Melinda Brown, a Director of Precision Biosciences Inc, purchased 1,135 shares of common stock on September 25, 2026 for $6.27 per share.
NASDAQ
Geno J Germano, a Director of Precision Biosciences Inc, purchased 2,609 shares of common stock on September 25, 2026 for $6.28 per share.
NASDAQ
Yang Luke Chen, a Director of 111, Inc., sold 180,880 shares of common stock on September 28, 2026.
NYSE
Fan (Fj) Jiang, CEO of Business Group of Alibaba Group Holding Ltd, reported multiple transactions in common stock on September 25, 2026.
NYSE
Siying Yu, General Counsel of Alibaba Group Holding Ltd, sold 6,764 shares of common stock on September 25, 2026 for $13.58 per share.
NYSE
Fang Jiang, Chief People Officer of Alibaba Group Holding Ltd, sold 4,889 shares of common stock on September 25, 2026 for $13.57 per share.
NYSE
Hong Xu, Chief Financial Officer of Alibaba Group Holding Ltd, sold 103,046 shares of common stock on September 25, 2026 for $13.68 per share.
NYSE
Yanjun Wang, CCO and GC of Sea Ltd, sold 2,200 shares of common stock on September 25, 2026.
NYSE
Yongdong Peng, Chief Executive Officer and a Director of KE Holdings Inc., sold 16,033,983 shares of common stock on September 25, 2026 for $5.27 per share.
NYSE
David Hytha, Chief Financial Officer of C1 Fund Inc., reported a transaction in 4,057 shares of common stock on September 5, 2025.
NYSE
Elliot Jin Han, Chief Investment Officer of C1 Fund Inc., purchased 5,000 shares of common stock on December 17, 2025 for $4.81 per share.
NYSE
Michael Xu Zhao, a Director of C1 Fund Inc., reported a transaction in 23,998 shares of common stock on September 5, 2025.
NASDAQ
VerifyMe, Inc. files an 8-K providing pro forma financial information for its proposed merger with Open World Ltd., detailing combined financial statements and the accounting treatment of the transaction.
NASDAQ
Sandra Boenisch, PFO & Treasurer of Anavex Life Sciences Corp., reported multiple transactions in common stock on September 24, 2026.
NASDAQ
Hui Liu, a Director of Rallybio Corp, reported multiple transactions in common stock on September 24, 2026.
NASDAQ
Chandler Robinson, Chief Executive Officer and a Director of Monopar Therapeutics, sold 29,056 shares of common stock on September 24, 2026.
NASDAQ
Kang Jyh Lee, a Director of Photronics Inc, sold 7,500 shares of common stock on September 24, 2026 for $29.50 per share.
NASDAQ
Steven B. Binder, a Director of Mannkind Corp, sold 39,051 shares of common stock on September 25, 2026 for $3.29 per share.
NASDAQ
Kevin Rubin, Chief Financial Officer of Zscaler, Inc., sold 519 shares of common stock on September 25, 2026.